Let's talk medical research

Adding sites is the fastest lever when enrollment stalls. Here is why it fails, and what to run first. When enrollment falls behind, expanding the ...

Patients clear your eligibility criteria, ask to be contacted, then vanish before they enroll. So why does a trial full of willing patients still ...

Finding the right patients for your clinical trial can feel like searching for a needle in a haystack. When enrollment stalls, timelines slip, and ...

Recruitment plans start with a headcount: this many patients with the condition, in these regions, so the trial is feasible. The math looks sound. ...

Enrollment is behind, so the plan is to add clinical research sites. It feels like progress. It looks like a fix. It’s also the most expensive way to ...

You selected your sites carefully. Six months in, enrollment is behind. The instinct: find better sites, bring more online. But site selection wasn’t ...

Market Feasibility helps test patient reach, understanding, and qualification signals earlier. Your patients don’t see a protocol. They see a ...

Clinical trials are moving toward faster data, faster signals, and faster decisions. The FDA recently announced real-time clinical trial ...

Are you still recruiting for “hypertension”… or for the full cardiometabolic reality your protocol actually requires? Hypertension used to be treated ...

Clinical trial referrals don’t usually fail because patients aren’t interested. They fail because too many patients are pushed downstream before ...